Insider Transactions in Q2 2022 at Entrada Therapeutics, Inc. (TRDA)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
4,000
-1.86%
|
$48,000
$12.0 P/Share
|
|
Jun 27
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
7,714
-10.62%
|
$100,282
$13.0 P/Share
|
|
Jun 06
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
38,304
+0.47%
|
$229,824
$6.39 P/Share
|
|
Jun 02
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
2,643
+0.07%
|
$13,215
$5.82 P/Share
|
|
May 24
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
23,823
+0.29%
|
$119,115
$5.84 P/Share
|
|
May 23
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
7,837
+0.19%
|
$39,185
$5.99 P/Share
|
|
May 20
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
16,849
+0.21%
|
$84,245
$5.84 P/Share
|
|
May 18
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
34,433
+0.43%
|
$172,165
$5.96 P/Share
|
|
May 17
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
18,511
+0.47%
|
$111,066
$6.13 P/Share
|
|
May 16
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
19,000
+0.49%
|
$95,000
$5.83 P/Share
|